
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5368482
[patent_doc_number] => 20090306041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Inhibitors of Bruton\'s tyrosine kinase'
[patent_app_type] => utility
[patent_app_number] => 12/322870
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58306
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322870
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322870 | Inhibitors of Bruton's tyrosine kinase | Feb 4, 2009 | Issued |
Array
(
[id] => 5527856
[patent_doc_number] => 20090197933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'IMIDAZOLINYLMETHYL ARYL SULFONAMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/365268
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8801
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365268 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE | Feb 3, 2009 | Abandoned |
Array
(
[id] => 5527855
[patent_doc_number] => 20090197932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'IMIDAZOLINYLMETHYL ARYL SULFONAMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/365260
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10346
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365260
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365260 | IMIDAZOLINYLMETHYL ARYL SULFONAMIDE | Feb 3, 2009 | Abandoned |
Array
(
[id] => 4524575
[patent_doc_number] => 07951833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471'
[patent_app_type] => utility
[patent_app_number] => 12/364949
[patent_app_country] => US
[patent_app_date] => 2009-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15875
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364949 | Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471 | Feb 2, 2009 | Issued |
Array
(
[id] => 5564952
[patent_doc_number] => 20090137805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/363838
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7590
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137805.pdf
[firstpage_image] =>[orig_patent_app_number] => 12363838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363838 | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES | Feb 1, 2009 | Abandoned |
Array
(
[id] => 5458889
[patent_doc_number] => 20090259041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'QUINOLINE CARBOXYLIC ACID-O,O BIS-ACYLOXY BORATE AND PROCESS OF MAKING'
[patent_app_type] => utility
[patent_app_number] => 12/362518
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3570
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20090259041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12362518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/362518 | QUINOLINE CARBOXYLIC ACID-O,O BIS-ACYLOXY BORATE AND PROCESS OF MAKING | Jan 29, 2009 | Abandoned |
Array
(
[id] => 5527780
[patent_doc_number] => 20090197857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/362221
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20268
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12362221
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/362221 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | Jan 28, 2009 | Issued |
Array
(
[id] => 9582484
[patent_doc_number] => 08772487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Fluorogenic hydrazine-substituted compounds'
[patent_app_type] => utility
[patent_app_number] => 12/864038
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 20834
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12864038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864038 | Fluorogenic hydrazine-substituted compounds | Jan 22, 2009 | Issued |
Array
(
[id] => 4534295
[patent_doc_number] => 07872046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/358454
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26722
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/872/07872046.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358454 | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use | Jan 22, 2009 | Issued |
Array
(
[id] => 5380486
[patent_doc_number] => 20090192325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'ENANTIOMERICALLY RESOLVING ACYLOXYALKYL THIOCARBONATES USED IN SYNTHESIZING ACYLOXYALKYL CARBAMATE PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/358532
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19124
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192325.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358532 | Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs | Jan 22, 2009 | Issued |
Array
(
[id] => 4475694
[patent_doc_number] => 07868043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-11
[patent_title] => 'Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/358507
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24680
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/868/07868043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358507
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358507 | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use | Jan 22, 2009 | Issued |
Array
(
[id] => 4485931
[patent_doc_number] => 07902376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates'
[patent_app_type] => utility
[patent_app_number] => 12/321533
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5674
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/902/07902376.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321533 | Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates | Jan 21, 2009 | Issued |
Array
(
[id] => 9951168
[patent_doc_number] => 08999955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological'
[patent_app_type] => utility
[patent_app_number] => 12/735463
[patent_app_country] => US
[patent_app_date] => 2009-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6579
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/735463 | Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological | Jan 18, 2009 | Issued |
Array
(
[id] => 8294735
[patent_doc_number] => 08222519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Merocyanine dye and photoelectric conversion device'
[patent_app_type] => utility
[patent_app_number] => 12/354965
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12607
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12354965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/354965 | Merocyanine dye and photoelectric conversion device | Jan 15, 2009 | Issued |
Array
(
[id] => 5490876
[patent_doc_number] => 20090291947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'PROLINE ANALOGS AS LIGANDS FOR CANNABINOID RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/350450
[patent_app_country] => US
[patent_app_date] => 2009-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32076
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291947.pdf
[firstpage_image] =>[orig_patent_app_number] => 12350450
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/350450 | Proline analogs as ligands for cannabinoid receptors | Jan 7, 2009 | Issued |
Array
(
[id] => 6545068
[patent_doc_number] => 20100288167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'LOW DIOL CONTENT MONOFUNCTIONAL ALKOXYPOLYALKYLENE GLYCOLS AND PROCESS FOR PRODUCING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/863531
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5710
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20100288167.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863531
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863531 | LOW DIOL CONTENT MONOFUNCTIONAL ALKOXYPOLYALKYLENE GLYCOLS AND PROCESS FOR PRODUCING THEM | Jan 6, 2009 | Abandoned |
Array
(
[id] => 5343315
[patent_doc_number] => 20090181965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'MODULATORS FOR AMYLOID BETA'
[patent_app_type] => utility
[patent_app_number] => 12/348370
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34968
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181965.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348370 | Modulators for amyloid beta | Jan 4, 2009 | Issued |
Array
(
[id] => 5580961
[patent_doc_number] => 20090176307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Compounds, Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/348786
[patent_app_country] => US
[patent_app_date] => 2009-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40274
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176307.pdf
[firstpage_image] =>[orig_patent_app_number] => 12348786
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/348786 | Compounds, Compositions and Methods | Jan 4, 2009 | Abandoned |
Array
(
[id] => 8577756
[patent_doc_number] => 08343966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 12/319234
[patent_app_country] => US
[patent_app_date] => 2009-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40416
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12319234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/319234 | Organic compounds | Jan 1, 2009 | Issued |
Array
(
[id] => 13984
[patent_doc_number] => 07803841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'EP2 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 12/346516
[patent_app_country] => US
[patent_app_date] => 2008-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52087
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803841.pdf
[firstpage_image] =>[orig_patent_app_number] => 12346516
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/346516 | EP2 receptor agonists | Dec 29, 2008 | Issued |